|
|
Welcome to the latest NMR newsletter from ACD/Labs. In this edition you'll find the most recent updates to our software and our featured publications. Contents:
ACD/NMR Workbook v2012—the Ultimate tool for Structure Characterization The latest version of ACD/NMR Workbook is here, featuring a more intuitive interface and many new features. Comprehensive project management preserves the links between related NMR experiments, allowing completely synchronized peak picking and immediate color-coded visual previews of structure assignment quality with the new Global Assignment Preview.
Watch the NMR Workbook overview movie to see the software at work. Unified Laboratory Intelligence & Decision Support
As part of a corporate R&D strategy, ULI can improve overall scientific productivity and substantially increase returns in life science (pharmaceutical, agrochemical, food and beverage, and personal care products), chemical, energy, consumer, industrial, and technology industries. ACD/Spectrus DB Release Completes ACD/Labs—Next Generation Cheminformatics Platform At PITTCON last month, we announced the commercial release of ACD/Spectrus DB, the third and final component of the new ACD/Spectrus Platform. This powerful and unique database preserves and makes useable the vast chemical, spectroscopic, and chromatographic knowledge generated by today's laboratories.
Tested in laboratories worldwide, Spectrus DB creates a collaborative project environment that does not stop at storing data for intellectual property rights preservation. It offers a searchable repository with access to the knowledge gained by individual scientists and groups, to benefit the whole organization for years to come. Spectrus DB completes the Spectrus integrated analytical and chemical knowledge management platform, fully embracing the concept of Unified Laboratory Intelligence. Learn more. The search for bioactive compounds reaches new depths—The €9M PharmaSea project
Scientists from the UK, Belgium, Norway, Spain, Ireland, Germany, Italy, Switzerland, and Denmark will work together to collect and screen samples of mud and sediment from huge, previously untapped, oceanic trenches. The large-scale, four-year project is backed by more than €9.5 million of EU funding and brings together 24 partners from 14 countries from industry, academia, and non-profit organizations. Advanced Chemistry Development UK, Ltd., is proud to be a contributing partner to this project. For more information visit http://www.pharma-sea.eu. PITTCON was a very exciting meeting for ACD/Labs this year with the release of ACD/Spectrus DB. ACD/Labs staff gave a number of presentations in various technical sessions, and MS product manager, Graham McGibbon, continued our tradition of running a workshop on Sunday afternoon. We were happy to connect with many customers, and meet face-to-face with instrument vendor partners, while also forging new relationships. ACD/Labs NMR Software Symposium—April 14, Asilomar Conference Grounds (California) At the 2013 Experimental NMR Conference we will host our annual NMR Software Symposium. We have a fantastic schedule lined up for this year, and hope that you can join us at this free event. This is your chance to see ACD/NMR Workbook in action, learn how scripting can streamline your workflow, and see the latest advances in automated structure verification and structure elucidation. View the NMR Software Symposium agenda ACD/Labs Symposium on Laboratory Intelligence—June 19–20, Neuchâtel (Switzerland) Building upon the legacy of our annual EUM, this year we are extending the invitation internationally for our inaugural Symposium on Laboratory Intelligence. Attend the symposium to hear how ACD/Labs is impacting R&D; learn how leveraging live data can provide efficiency and productivity gains throughout your organization; and hear from industry thought leaders about the challenges of managing global operations. Our preliminary agenda includes speakers from Eli Lilly (US), Merck (Germany), Royal Society of Chemistry (UK), and our hosts Philip Morris International (Switzerland), amongst many others. Learn more about the meeting and register today! In January we launched our new website, with a new look and more efficient and cohesive navigation. All the existing information is preserved, but we've made it easier to learn about our core products and have highlighted our most exciting solutions. Take a few moments to have a look around! The new www.acdlabs.com For more information on any of these stories, please e-mail info@acdlabs.com or visit us at www.acdlabs.com.
|
The collaborative PharmaSea project will bring European researchers to some of the deepest, coldest, and hottest places on the planet. The project focuses on biodiscovery research and the development and commercialization of new bioactive compounds from marine organisms, including deep-sea sponges and bacteria, to evaluate their potential as novel drug leads or ingredients for nutrition or cosmetic applications. 
